These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1119 related items for PubMed ID: 26169986

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis.
    Chen J, Wang W, Wang H, Liu X, Guo X.
    Drug Discov Ther; 2014 Feb; 8(1):33-41. PubMed ID: 24647156
    [Abstract] [Full Text] [Related]

  • 5. The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells.
    Kang Y, Park MA, Heo SW, Park SY, Kang KW, Park PH, Kim JA.
    Biochim Biophys Acta; 2013 Mar; 1830(3):2638-48. PubMed ID: 23246576
    [Abstract] [Full Text] [Related]

  • 6. Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1.
    Sims JT, Ganguly SS, Bennett H, Friend JW, Tepe J, Plattner R.
    PLoS One; 2013 Mar; 8(1):e55509. PubMed ID: 23383209
    [Abstract] [Full Text] [Related]

  • 7. Sunitinib Inhibits Breast Cancer Cell Proliferation by Inducing Apoptosis, Cell-cycle Arrest and DNA Repair While Inhibiting NF-κB Signaling Pathways.
    Korashy HM, Maayah ZH, Al Anazi FE, Alsaad AM, Alanazi IO, Belali OM, Al-Atawi FO, Alshamsan A.
    Anticancer Res; 2017 Sep; 37(9):4899-4909. PubMed ID: 28870911
    [Abstract] [Full Text] [Related]

  • 8. The Hsp90 inhibitor SNX-2112, induces apoptosis in multidrug resistant K562/ADR cells through suppression of Akt/NF-κB and disruption of mitochondria-dependent pathways.
    Wang R, Shao F, Liu Z, Zhang J, Wang S, Liu J, Liu H, Chen H, Liu K, Xia M, Wang Y.
    Chem Biol Interact; 2013 Sep 05; 205(1):1-10. PubMed ID: 23777986
    [Abstract] [Full Text] [Related]

  • 9. Apigenin overcomes drug resistance by blocking the signal transducer and activator of transcription 3 signaling in breast cancer cells.
    Seo HS, Ku JM, Choi HS, Woo JK, Lee BH, Kim DS, Song HJ, Jang BH, Shin YC, Ko SG.
    Oncol Rep; 2017 Aug 05; 38(2):715-724. PubMed ID: 28656316
    [Abstract] [Full Text] [Related]

  • 10. Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.
    Hu Y, Zang J, Cao H, Wu Y, Yan D, Qin X, Zhou L, Fan F, Ni J, Xu X, Sha H, Liu S, Yu S, Wang Z, Ma R, Wu J, Feng J.
    Oncotarget; 2017 Feb 28; 8(9):15802-15814. PubMed ID: 28178657
    [Abstract] [Full Text] [Related]

  • 11. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
    Li J, Xu LZ, He KL, Guo WJ, Zheng YH, Xia P, Chen Y.
    Breast Cancer Res; 2001 Feb 28; 3(4):253-63. PubMed ID: 11434876
    [Abstract] [Full Text] [Related]

  • 12. [Norcantharidin potentialize the chemosensitivity of adriamycin through the NF-κB/IκBα signaling pathway].
    Song XN, Du HF, Yu LJ, Meng YF, Lü HY, Sun LX, Meng JB, Zhang JQ.
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec 28; 32(12):809-13. PubMed ID: 22339951
    [Abstract] [Full Text] [Related]

  • 13. Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells.
    Abdin SM, Tolba MF, Zaher DM, Omar HA.
    Chem Biol Interact; 2021 May 01; 340():109450. PubMed ID: 33775688
    [Abstract] [Full Text] [Related]

  • 14. Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin.
    Liu T, Peng H, Zhang M, Deng Y, Wu Z.
    Eur J Pharmacol; 2010 Sep 01; 641(1):15-22. PubMed ID: 20483353
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.
    Jiang J, Wang X, Cheng K, Zhao W, Hua Y, Xu C, Yang Z.
    Mol Med Rep; 2016 Jun 01; 13(6):4745-50. PubMed ID: 27082231
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate.
    Ma G, Tabanca N, Husnu Can Baser K, Kirimer N, Pasco DS, Khan IA, Khan SI.
    Cancer Chemother Pharmacol; 2009 Mar 01; 63(4):673-80. PubMed ID: 18597088
    [Abstract] [Full Text] [Related]

  • 18. Quinalizarin induces ROS‑mediated apoptosis via the MAPK, STAT3 and NF‑κB signaling pathways in human breast cancer cells.
    Zang YQ, Feng YY, Luo YH, Zhai YQ, Ju XY, Feng YC, Sheng YN, Wang JR, Yu CQ, Jin CH.
    Mol Med Rep; 2019 Nov 01; 20(5):4576-4586. PubMed ID: 31702038
    [Abstract] [Full Text] [Related]

  • 19. Cucurbitacin B reverses multidrug resistance by targeting CIP2A to reactivate protein phosphatase 2A in MCF-7/adriamycin cells.
    Cai F, Zhang L, Xiao X, Duan C, Huang Q, Fan C, Li J, Liu X, Li S, Liu Y.
    Oncol Rep; 2016 Aug 01; 36(2):1180-6. PubMed ID: 27350399
    [Abstract] [Full Text] [Related]

  • 20. [Effects of cucurbitacin B on cell proliferation and apoptosis in Hep-2 cells].
    Liu T, Zhang M, Deng Y, Zhang H, Sun C, Yang X, Ji W.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 May 01; 22(9):403-7. PubMed ID: 18652313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.